HYDROCHLOROTHIAZIDE
- Product NDC
- 70518-2540
- 11-digit product format
- 705182540
- Labeler code
- 70518
- Product ID
- 70518-2540_dc25cf2f-05c0-036b-e053-2a95a90a396a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- HYDROCHLOROTHIAZIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA040702
- Marketing category
- ANDA
- Marketing start
- 2020-01-13
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE
- Active strength
- 13 mg/1
- Pharmacologic classes
- Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70518-2540 | HYDROCHLOROTHIAZIDE TABLET [REMEDYREPACK INC.] | 5 | Legacy NDC | 20220409_f30a7b7c-1271-4243-8203-b9d6ab3abf09.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2540-0 | 70518254000 | 30 TABLET in 1 BLISTER PACK (70518-2540-0) | 30 tablet | 2020-01-13 | 0000-00-00 | No | No | Current |